Video Experimental Relacionado

Updated: Jan 20, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

Trasplante de hígado para metástasis de tumores neuroendocrinos

Andrea Boscà Robledo¹, Eva María Montalvá Orón², Rafael López-Andújar¹

¹Cirugía Hepatobiliopancreática y Trasplante, Hospital Universitari i Politècnic La Fe, España.

Revista espanola de enfermedades digestivas

|January 19, 2026

Resumen

El trasplante de hígado puede mejorar la supervivencia de pacientes seleccionados con metástasis hepáticas de tumores neuroendocrinos. Se aplican criterios de selección estrictos y la derivación a centros con experiencia es crucial para los casos indicados.

Área de la Ciencia:

Cirugía Hepatobiliar
Oncología Quirúrgica
Cirugía de Trasplantes

Sus antecedentes:

Los tumores neuroendocrinos (TNE) pueden metastatizar al hígado.
Las metástasis hepáticas de los TNE pueden afectar significativamente la supervivencia del paciente.
El trasplante de hígado es una opción de tratamiento potencial para las metástasis hepáticas avanzadas de TNE.

Objetivo del estudio:

Evaluar el papel y las indicaciones del trasplante de hígado en pacientes con metástasis hepáticas de tumores neuroendocrinos.
Definir los criterios de selección para el trasplante de hígado en esta población de pacientes.
Enfatizar la importancia de los centros multidisciplinarios con experiencia.

Principales métodos:

Revisión de la literatura actual y las guías clínicas.
Análisis de los resultados en pacientes sometidos a trasplante de hígado por metástasis hepáticas de TNE.
Discusión de las estrategias de selección y manejo de pacientes.

Principales resultados:

El trasplante de hígado puede mejorar la supervivencia general y libre de enfermedades en pacientes cuidadosamente seleccionados.
Son esenciales criterios de selección estrictos para obtener resultados exitosos.
El manejo multidisciplinario en centros con experiencia es fundamental.

Conclusiones:

El trasplante de hígado es una opción viable para pacientes específicos con metástasis hepáticas de tumores neuroendocrinos.
La cuidadosa selección de pacientes y la derivación a centros expertos son primordiales.
Este enfoque ofrece beneficios de supervivencia mejorados en los casos indicados.

Palabras clave:

trasplante de hígado tumores neuroendocrinos metástasis hepáticas cirugía hepatobiliar oncología quirúrgica cirugía de trasplantes

Más Videos Relacionados

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Videos de Conceptos Relacionados

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

We present a simple agarose overlay platform to grow 3D multicellular spheroids using neuroendocrine cancer cell lines. This method provides a very convenient way to examine the effect of therapeutic drugs on the neuroendocrine tumor cells. It could also help us establish human neuroendocrine tumor spheroids for cancer...

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Here, we present a protocol how to perform an isolated liver perfusion (IHP) with melphalan and we also discuss IHP as a treatment option for liver metastases of uveal...

Characterization of Small Bowel Neuroendocrine Tumor Spheroids Using Immunofluorescence

Characterization of Small Bowel Neuroendocrine Tumor Spheroids Using Immunofluorescence

Source: Ear, P. H., et. al. Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids. J. Vis. Exp. (2019)This video demonstrates the immunofluorescence staining of small bowel neuroendocrine tumor spheroids. The spheroids are fixed, permeabilized, and blocked and are then incubated with primary and secondary antibodies. A dye is added to stain nuclei before mounting and visualizing them under a fluorescent...

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Stereotactic body radiotherapy (SBRT) requires rigorous accuracy and precision for delivering high radiation doses per fraction to small treatment volumes to improve tumor control and simultaneously reduce toxicity. Herein, we present a noninvasive and clinically convenient respiratory motion management protocol for SBRT for liver metastases.

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Neuroendocrine tumors (NETs) originate from neuroendocrine cells of the neural crest. They are slow growing and challenging to culture. We present an alternative strategy to grow NETs from the small bowel by culturing them as spheroids. These spheroids have small bowel NET markers and can be used for drug...

Liver Cold Storage and Transplantation in the Cold-Adaptive Daurian Ground Squirrels

Liver Cold Storage and Transplantation in the Cold-Adaptive Daurian Ground Squirrels

Here, we present a protocol to establish a long-term liver cold storage and transplantation model in Daurian ground squirrel (DGS), which has been technically challenging in standard rodent models.